New York Senate Bill S08770

New York 2025-2026 Regular Session

• Introduced: 1/8/26
• Refer: 1/8/26

Caption

Relates to requirements regarding employers including opioid antagonists where first aid kits are required by federal law; amends the effectiveness thereof.

Impact

If enacted, S08770 would significantly affect workplace safety legislation in the state. It would mandate all federally governed employers to stock opioid antagonists, thereby aligning state regulations with federal safety requirements. This aligns with national efforts to combat the opioid crisis by ensuring immediate access to overdose reversal drugs in environments where individuals are often at risk, thereby potentially saving lives and reducing the adverse impacts of opioid overdoses in workplaces.

Summary

Bill S08770 proposes amendments to the existing labor law by requiring employers to include an opioid antagonist among first aid supplies mandated by federal regulations like the Occupational Safety and Health Act. The bill aims to enhance safety protocols in workplaces, specifically targeting industries where the risk of opioid overdoses is prevalent. By ensuring that these life-saving medications are readily available, the bill seeks to provide necessary resources for employees in emergency situations.

Contention

The bill has stirred discussions around its implications for state law and employer responsibilities. Opponents may argue that the requirements could impose additional costs and logistical challenges for employers, especially small businesses. There may be concerns regarding the training required for staff to administer these medications appropriately and the potential legal liabilities that might arise in case of misuse or adverse reactions. Consequently, the bill could ignite debates on the balance between ensuring workplace safety and the fiscal burdens on employers.